The increasing interest in NAD+ formulations, particularly at significant doses like 1000mg, is coinciding with the rising profile of Retatrutide – a groundbreaking GLP-1 peptide gaining attention across https://socialbuzzfeed.com/story7847849/nad-supplement-the-new-drug-a-uk-focus